Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

V. Jevtović-Todorović, S. M. Todorović, S. Mennerick, S. Powell, K. Dikranian, N. Benshoff, C. F. Zorumski, J. W. Olney

Research output: Contribution to journalArticlepeer-review

474 Scopus citations

Abstract

Extensive research has failed to clarify the mechanism of action of nitrous oxide (N20, laughing gas), a widely used inhalational anesthetic and drug of abuse. Other general anesthetics are thought to act by one of two mechanisms-blockade of NMDA glutamate receptors or enhancement of GABAergic inhibition1. Here we show that N2O, at anesthetically-relevant concentrations, inhibits both ionic currents and excitotoxic neurodegeneration mediated through NMDA receptors and, like other NMDA antagonists, produces neurotoxic side effects which can be prevented by drugs that enhance GABAergic inhibition. The favorable safety record of N20 maybe explained by the low concentrations typically used and by the fact that it is usually used in combination with GABAergic anesthetics that counteract its neurotoxic potential.

Original languageEnglish
Pages (from-to)460-463
Number of pages4
JournalNature medicine
Volume4
Issue number4
DOIs
StatePublished - Apr 1998

Fingerprint

Dive into the research topics of 'Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin'. Together they form a unique fingerprint.

Cite this